NDI Notification Guidance Deadline Included In Senate Draft Bill For FDA User Fee Programs
HELP Committee Chairwoman Patty Murray, and ranking member Richard Burr also include supplement registration requirement in discussion draft for reauthorizing FDA’s user fee programs for prescription, generic and biosimilar drugs and medical devices.
You may also be interested in...
US Dietary Supplement Industry In 2023: Little New Expected In NDI Notification Enforcement
Chief executives of OTC drug and supplement industry trade groups discussed potential market and regulatory developments affecting their members’ businesses. HBW Insight concludes series here reporting on supplement sector’s outlook for FDA potentially resolving its protracted struggle with NDI notification requirement.
Protection For NDIs Bigger Concern In US Than Giving More Time For Notifications, CRN Contends
FDA should protect companies which “do the right thing” by submitting new dietary ingredient notifications, CRN's Steve Mister said during FDLI's annual conference.
No Longer Draft, Senate Mandatory Supplement Registration Bill Gets Flood Of Opposition
Some stakeholders have supported mandatory listing but they join opponents questioning legislation also authorizing FDA to prohibit sales of products compliant with manufacturing and labeling regulations but deficient, incomplete or late with registration information required for the agency.